PAVmed Inc. — Company profile
Healthcare · Medical Devices · United States
Last price 1.97 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 13.78M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company’s lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck device. Its product pipeline also comprises EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.
Details
| Name | PAVmed Inc. |
| Sector | Healthcare |
| Industry | Medical Devices |
| Employees | 41 |
| Founded | 2014 |
| Ipo Date | 2016-04-28 |
| Ceo | Lishan Aklog |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US70387R5028 |
| Cusip | 70387R502 |
| Cik | 0001624326 |
| Sic | 3841 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Dr. Lishan Aklog M.D. | Chairman and Chief Executive Officer |
| Dennis M. McGrath CPA | President and Chief Financial Officer |
| Shaun M. O'Neill M.B.A. | Executive Vice President and Chief Operating Officer |
| Michael Adam Gordon | Executive Vice President, General Counsel and Secretary |
| Dr. Brian J. deGuzman M.D. | Executive Vice President, Chief Technology and Compliance Officer |
| Dr. Suman M. Verma M.D., Ph.D. | Senior Vice President of Molecular Genetics and Chief Scientific Officer |
| Matthew Riley | Senior Director of Investor Relations |
| Dr. Deepika A. Lakhani Ph.D. | Senior Vice President, Chief Regulatory and Quality Officer |
| Dr. Victoria T. Lee M.D. | Executive Vice President and Chief Medical Officer |
| Joseph Virgilio | SVice President and Chief Business Officer of Medical Devices |
Contact
| Address | 360 Madison Avenue, 25th Floor, New York, New York 10017, United States |
| Phone | 917 813 1828 |
| Website | https://www.pavmed.com |